The results showed that several cytokines reported to play important roles in tumor promotion, such as IL6, IL8, MCP1, and GRO (CXCL1, 2, 3), exhibited upregulated expression in the LY2835219 monotherapy group and downregulated expression in the combination therapy group (Fig. 3B). This evidence concerns the gene CCL2 and neoplasm.